ZYXI News and Press, Zynex Inc. From 05/05/21

Order growth, and with it revenue growth, will accelerate again after already raking up a 140% growth in Q1. Salesforce productivity has a lot of upside; with hiring slowing down and even halting in H1 2020, profitability will recover. Lowering inventories and other cost and a $10...

The following slide deck was published by Zynex, Inc. in conjunction with their 2021 Q1 earnings call. For further details see: Zynex, Inc. 2021 Q1 - Results - Earnings Call Presentation

Image source: The Motley Fool. Zynex, Inc (NASDAQ: ZYXI) Q1 2021 Earnings Call Apr 29, 2021 , 4:15 p.m. ET Operator Continue reading For further details see: Zynex, Inc (ZYXI) Q1 2021 Earnings Call Transcript

Start Time: 16:15 End Time: 17:01 Zynex, Inc. (ZYXI) Q1 2021 Earnings Conference Call April 29, 2021, 16:15 PM ET Company Participants Thomas Sandgaard - Founder, Chairman and CEO Dan Moorhead - CFO Conference Call Participants Drew Stafford - Piper Sandler Jeffrey Cohen - Ladenburg Thalmann ...

Zynex (ZYXI): Q1 GAAP EPS of -$0.02 beats by $0.01.Revenue of $24.1M (+58.2% Y/Y) beats by $0.43M.Outlook: The estimated range for second quarter revenue is between $31.0 and $32.5 million with Adjusted EBITDA between $3.0 and $4.0 million. The revenue estimate is approximately 61% to 69% abo...

Zynex Announces 2021 First Quarter Earnings PR Newswire ENGLEWOOD, Colo. , April 29, 2021 /PRNewswire/ -- 2021 First Quarter Revenue increased 58% year over year to $24.1 million Orders increased 140% Net loss of ...

Zynex Appoints Donald Gregg as Vice President of Sales and Operations of Monitoring Solutions Division PR Newswire ENGLEWOOD, Colo., April 20, 2021 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manuf...

Zynex Schedules 2021 First Quarter Earnings Call PR Newswire ENGLEWOOD, Colo., April 19, 2021 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI) , an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices f...

Zynex is well positioned to capitalize on recent fundamental momentum in sales volume and top-line growth. Such momentum hasn't yet translated to share performance, and the market continues to discount Zynex shares. Questions around management's posture on inventory remain, and la...

Zynex ([[ZYXI]] -3.5%) announces Q1 order growth of 140% Y/Y, and confirms its previous revenue estimate 1Q21 of between $23M and $24.5M vs. consensus of $23.8M and Adj. EBITDA loss estimate of between $0.5M and $1.5M.FY21 revenue estimate is between $135M and $150M vs. consensus of $138.03M;...